Contractors › THE EMMES COMPANY, LLC
THE EMMES COMPANY, LLC: federal contracts
$17.0Mobligated, last 24 months
23contract actions
$4.7Mlargest single action
25contracts ending within 18 months
| UEI | NBQCBJ6FXBU4 |
|---|---|
| CAGE code | 3EX59 |
| Location | ROCKVILLE, MD, USA |
| SAM registration | Active when retrieved (07 October 2026); expires 13 July 2027 |
| SBA certifications | None on record |
| In business since | 04 November 1977 |
Registration details from SAM.gov, retrieved 07 October 2026. Award figures from USASpending.gov (task orders and definitive contracts; IDIQ ceilings excluded), updated nightly. Last award action: 15 September 2026.
Agencies they work for
| Buyer | Obligations, 3 yrs | Contracts |
|---|---|---|
| National Institutes of Health (NIH) | $71.4M | 35 |
| Office of the Assistant Secretary for Financial Resources | $125K | 1 |
Industries (NAICS)
| NAICS | Industry | Obligations, 24 mo | Awards |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $15.2M | 8 |
| 541690 | Other Scientific and Technical Consulting Services | $1.6M | 14 |
| 541511 | Custom Computer Programming Services | $125K | 1 |
What they deliver (product and service codes)
| PSC | Description | Obligations, 36 mo | Awards |
|---|---|---|---|
| AN11 | Health R&D Services; Health Care Services; Basic Research | $40.1M | 21 |
| R699 | Support- Administrative: Other | $27.4M | 1 |
| R499 | Support- Professional: Other | $2.5M | 20 |
| AN12 | Health R&D Services; Health Care Services; Applied Research | $1.2M | 2 |
| AN42 | Health R&D Services; Health Care - Other; Applied Research | $223K | 1 |
| DA01 | It and Telecom - Business Application/Application Development Support Services (Labor) | $125K | 1 |
Contracts expiring in the next 18 months
25 contracts worth $419.2M.
| Incumbent | Buyer | What | Value | Ends | Est. solicitation | Record |
|---|---|---|---|---|---|---|
| THE EMMES COMPANY, LLC | NIH | 541511 Custom Computer Programming Services | $14.2M | 14 October 2026 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $30.1M | 31 October 2026 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $3.6M (2 orders) | 01 November 2026 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $612K | 30 November 2026 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541711 Research and Development in Biotechnology | $174K | 31 December 2026 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $4.1M (3 orders) | 31 January 2027 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541713 Research and Development in Nanotechnology | $176.6M | 28 February 2027 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $2.4M | 28 February 2027 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541690 Other Scientific and Technical Consulting Services | $239K (2 orders) | 28 February 2027 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $2.1M | 31 March 2027 | Now / imminent | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541690 Other Scientific and Technical Consulting Services | $402K | 30 April 2027 | ~Q4 2026 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541711 Research and Development in Biotechnology | $66.0M | 28 May 2027 | ~Q4 2026 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541611 Administrative Management and General Management Consulting Services | $51.1M | 31 May 2027 | ~Q4 2026 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541690 Other Scientific and Technical Consulting Services | $83K | 02 June 2027 | ~Q4 2026 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $13.5M | 06 August 2027 | ~Q1 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $2.3M (2 orders) | 27 August 2027 | ~Q1 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541611 Administrative Management and General Management Consulting Services | $27.4M | 31 August 2027 | ~Q1 2027 | USASpending |
| THE EMMES COMPANY, LLC | Office of the Assistant Secretary for Financial Resources | 541511 Custom Computer Programming Services | $125K | 14 September 2027 | ~Q1 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) | $9.0M | 29 September 2027 | ~Q2 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $3.4M (2 orders) | 30 September 2027 | ~Q2 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $670K | 30 November 2027 | ~Q2 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $990K | 31 December 2027 | ~Q3 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $1.7M | 29 February 2028 | ~Q3 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $4.4M (2 orders) | 31 March 2028 | ~Q4 2027 | USASpending |
| THE EMMES COMPANY, LLC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $3.9M | 02 April 2028 | ~Q4 2027 | USASpending |
Contracts and task orders from USASpending.gov (FPDS) whose period of performance ends within 18 months, valued at $25K or more, excluding IDIQ ceilings and government-owned, contractor-operated facility contracts. Co-terminous orders from the same vendor, agency, NAICS and PSC ending in the same month are grouped. The solicitation date is an estimate (about six months before the contract ends): FedSift does not know whether a follow-on has been posted, so check SAM.gov.
Verify on SAM.gov: exclusions search (public). The SAM.gov entity record itself requires a SAM.gov sign-in.
Considering THE EMMES COMPANY, LLC as a teaming partner?
FedSift's Partner Finder shows their certifications, registration status and exclusions in one dossier, and ranks alternatives for the role you need. Free plan available, no credit card.